CANCELLED: Tailored proteins and polypeptides as versatile building blocks for nanomedicine applications
Cancelled
Event details
| Date | 25.02.2013 |
| Hour | 13:15 |
| Speaker |
Tanja Weil of Universitat Ulm Bio : Tanja Weil joined Ulm University as Director of the Institute of Organic Chemistry III and Macromolecular Chemistry in 2010. She studied chemistry (1993–1998) at the TU Braunschweig (Germany) and the University of Bordeaux I (France) and completed her PhD at the MPI for Polymer Research under the supervision of K. Müllen. In 2003 she received the Otto Hahn Medal of the Max Planck Society. From 2002 to 2008 she managed different leading positions at Merz Pharmaceuticals GmbH (Frankfurt) from Section Head Medicinal Chemistry to Director of Chemical Research and Development. In 2005 Tanja Weil was also appointed to the MPI for Polymer Research and in 2008 she accepted an Associate Professor position at the National University of Singapore. In 2011 she became member of the Board of Directors of the International Graduate School for Molecular Medicine and in 2011 she has co-founded the “Ulm Competence Center for Peptide Pharmaceuticals” (UPEP). In 2012 Tanja Weil has been awarded the ERC Synergy Grant together with Fedor Jelezko and Martin Plenio. Her current scientific interests include the biohybrid materials, dendrimers and artificial proteins. |
| Location | |
| Category | Conferences - Seminars |
Proteins possess attractive features such as a large number of reactive surface functionalities, an accurately known chain length and a defined number of functional groups at distinct locations within the peptide backbone, low size-dispersity as well as intrinsic biocompatibility. Therefore, they represent attractive and versatile precursors for the preparation of giant biopolymers, macromolecular drugs as well as supramolecular, bioactive assemblies. They offer great opportunities for the stabilization of nanoparticles for bioimaging applications and allow the attachment of large numbers of drugs and contrast reagents or the construction of defined supramolecular assemblies with tunable biological activities. Such protein-derived biohybrids have a great potential for in vivo therapy and pave the way to intelligent vehicles for nanomedicine applications.
Practical information
- General public
- Free
Organizer
- Frauenrath Holger <[email protected]>
Contact
- Frauenrath Holger <[email protected]>